Depression will soon be the leading cause of years lived with disability worldwide
1 and contributes even more to disability when comorbid with a chronic medical disorder.
2,3 Every year, approximately 1.2 million Americans survive an acute coronary syndrome (ACS) event,
4 and many have clinically significant and persistent depression.
5,6 Patients with post-ACS depression have significantly more ambulatory medical appointments, emergency department visits, and higher health care costs than similar patients without depression.
7,8 Post-ACS depression is also associated with a 150% increased risk of ACS recurrence
9 and a 100% increase in the relative risk of all-cause mortality,
2,10,11 and persistent depression after an ACS event is associated with an even higher morbidity and mortality risk.
3,12 Reducing persistent post-ACS depression is therefore an important public health objective.